2022 Impact Report

Ashley RosenbrockFoundation Blog, Home Page, Research News

Your support of the Les Turner ALS Foundation is felt by people living with ALS, caregivers, families and loved ones everywhere. By making a donation or volunteering your time, you helped ensure they had the support they needed – and …

New results show promise in treatment of SOD1-ALS

lesturnerClinical Trials, Foundation Blog, Home Page, Research News

New results from the Phase 3 clinical trial of tofersen, a drug in development by Biogen, have shown promise in treatment of superoxide dismutase 1 (SOD1) amyotrophic lateral sclerosis (ALS). According to the 12-month data, earlier initiation of treatment with …

NU-9 Update: Experimental drug repairs upper motor neurons in mouse model

lesturnerFoundation Blog, Home Page, Research News

As connecting fibers between motor neurons, axons help deliver vital messages between the brain and the spinal cord. For people living with ALS, deteriorating axons cause that connection to break, contributing to paralysis and death. Early research on NU-9, an …